Tetra Bio-Pharma Inc.
TBP
Rankning i aktier
#35435
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Aktiekurs
$0.01851783
Senast synkroniserad: 2023-05-23
Marknadsvärde
$3.71M
Förändring (1 dag)
-0.04%
Förändring (1 år)
1,443.15%
Land
CA
Handel Tetra Bio-Pharma Inc. (TBP)
Kategori
Healthcare
Historik för aktiesplit för Tetra Bio-Pharma Inc. (TBP)
Aktien Tetra Bio-Pharma Inc. (symbol: TBP) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 21, 2026.
En TBP-aktie köpt före Oct 21, 2026 motsvarar nu 0 TBP-aktier.
Den senaste spliten skedde den Oct 21, 2026.
En TBP-aktie köpt före Oct 21, 2026 motsvarar nu 0 TBP-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
